MX2010008293A - Metodos para tratar la piel con ingredientes aromaticos activos en la piel. - Google Patents

Metodos para tratar la piel con ingredientes aromaticos activos en la piel.

Info

Publication number
MX2010008293A
MX2010008293A MX2010008293A MX2010008293A MX2010008293A MX 2010008293 A MX2010008293 A MX 2010008293A MX 2010008293 A MX2010008293 A MX 2010008293A MX 2010008293 A MX2010008293 A MX 2010008293A MX 2010008293 A MX2010008293 A MX 2010008293A
Authority
MX
Mexico
Prior art keywords
skin
skin cell
aromatic
reducing
methods
Prior art date
Application number
MX2010008293A
Other languages
English (en)
Inventor
Hines Michelle
Walke Bob
Gomez Cristie
Florence Tiffany
Original Assignee
Mary Kay Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mary Kay Inc filed Critical Mary Kay Inc
Publication of MX2010008293A publication Critical patent/MX2010008293A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe un método para tratar la piel, que reduce el daño oxidante a una célula de la piel, que reduce la actividad de lipoxigenasa (LO) en una célula de la piel, que reduce la actividad de ciclooxigenasa (COX) en una célula de la piel, que reduce el factor-a de necrosis tumoral (TNF-a) en una célula de la piel, o que reduce la actividad de la enzima metaloproteinasa de matriz en una célula de la piel, que comprende poner en contacto la piel o una célula de la piel con un ingrediente aromático activo en la piel.
MX2010008293A 2008-02-01 2009-01-29 Metodos para tratar la piel con ingredientes aromaticos activos en la piel. MX2010008293A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2563108P 2008-02-01 2008-02-01
US12/105,957 US20090197939A1 (en) 2008-02-01 2008-04-18 Methods of treating skin with aromatic skin-active ingredients
PCT/US2009/032430 WO2009099890A2 (en) 2008-02-01 2009-01-29 Methods of treating skin with aromatic skin-active ingredients

Publications (1)

Publication Number Publication Date
MX2010008293A true MX2010008293A (es) 2011-03-15

Family

ID=40932318

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2010008293A MX2010008293A (es) 2008-02-01 2009-01-29 Metodos para tratar la piel con ingredientes aromaticos activos en la piel.
MX2013001686A MX360399B (es) 2008-02-01 2009-01-29 Metodos para tratar la piel con ingredientes aromaticos activos en la piel.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2013001686A MX360399B (es) 2008-02-01 2009-01-29 Metodos para tratar la piel con ingredientes aromaticos activos en la piel.

Country Status (11)

Country Link
US (3) US20090197939A1 (es)
EP (1) EP2257284B1 (es)
KR (1) KR101199672B1 (es)
CN (2) CN101496799B (es)
BR (1) BRPI0907086B1 (es)
CA (1) CA2713770C (es)
EA (1) EA020293B1 (es)
ES (1) ES2540743T3 (es)
HK (1) HK1199834A1 (es)
MX (2) MX2010008293A (es)
WO (1) WO2009099890A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9284274B2 (en) 2005-12-07 2016-03-15 Ramot At Tel-Aviv University Ltd. Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US9284252B2 (en) 2009-06-09 2016-03-15 Sepal Pharma Ltd. Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
US9585823B2 (en) 2010-01-07 2017-03-07 The Gillette Company Personal care compositions comprising a multi-active system for down regulating cytokines irritation
US9044429B2 (en) 2010-01-15 2015-06-02 The Gillette Company Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof
US8883220B2 (en) 2011-09-16 2014-11-11 Nanocare Technologies, Inc. Compositions of jasmonate compounds
US9402794B2 (en) * 2011-12-07 2016-08-02 Mary Kay Inc. Topical skin care formulation
KR102135989B1 (ko) * 2012-09-28 2020-07-20 가부시키가이샤 시세이도 Vegfc 생산 촉진제
EP3240524B1 (en) 2014-12-30 2020-01-01 Unilever N.V. A skin lightening composition comprising 4-hexylresorcinol and ilomastat
MX2017008655A (es) 2014-12-31 2018-04-10 Nanocare Tech Inc Derivados de jasmonato y composiciones de los mismos.
AU2016246681A1 (en) 2015-04-06 2017-10-26 The Trustees Of The University Of Pennsylvania Compositions and methods for increasing, or preventing or reversing loss of, skin pigmentation in a mammalian subject
US20170000713A1 (en) * 2015-06-30 2017-01-05 The Gillette Company Personal care compositions comprising a sensate
US9789070B2 (en) * 2015-07-28 2017-10-17 Elc Management Llc Sheet packs for treating facial or body surfaces
ITUA20163604A1 (it) 2016-05-19 2017-11-19 Giuliani Spa Composti atti a promuovere la crescita dei capelli nell'uomo e/o a fermarne o ritardarne la caduta, e composizioni per tali usi
KR101702389B1 (ko) * 2016-06-22 2017-02-03 연세대학교 산학협력단 이오논 또는 이의 염을 유효성분으로 함유하는 피부보습 개선, 피부각질 제거, 피부탄력 증진, 홍반 억제, 피부주름 개선 또는 피부광노화 개선 효과를 갖는 조성물
CN106822067A (zh) * 2017-01-22 2017-06-13 新乡医学院 治疗动脉粥样硬化的药物组合物及该药物组合物的应用
KR101777992B1 (ko) * 2017-04-03 2017-09-12 연세대학교 산학협력단 자스몬(Jasmone) 또는 이의 염을 유효성분으로 함유하는 피부주름 개선, 보습, 탄력증진, 각질제거, 홍반억제 또는 피부광노화 개선용 조성물
KR20220048378A (ko) * 2020-10-12 2022-04-19 주식회사 에피바이오텍 디하이드로퓨란-2(3h)-온 이량체를 포함하는 피부미백용 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461622B2 (en) * 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
US6147037A (en) * 1996-08-19 2000-11-14 The Procter & Gamble Company Fragrance delivery systems
US6126930A (en) * 1997-02-13 2000-10-03 The Procter & Gamble Company Spray compositions
ES2193014T3 (es) * 1999-02-19 2003-11-01 Givaudan Sa 3-metiloct-6-enoles 6-sustituidos.
JP2001207188A (ja) * 2000-01-28 2001-07-31 Pola Chem Ind Inc 過酸化脂質消去用の香料組成物
US6495497B1 (en) * 2001-09-26 2002-12-17 International Flavors & Fragrances Inc. Use of 4-ethyloctanal in perfume compositions
US20040137024A1 (en) * 2002-10-29 2004-07-15 L'oreal Smoothing out wrinkles with a fragrancing composition
KR100962988B1 (ko) * 2003-02-07 2010-06-10 (주)아모레퍼시픽 Ｍｕｓｋ를 함유하는 피부건조 개선용 피부외용제 조성물
FR2856295B1 (fr) * 2003-06-18 2008-03-28 Jean Noel Thorel Methode de traitement esthetique, pour lutter contre l'apparition des rides et/ou les attenuer
US20060084589A1 (en) * 2004-10-20 2006-04-20 Vlad Florin J Solubilizing systems for flavors and fragrances
GB0425305D0 (en) 2004-11-17 2004-12-15 Givaudan Sa Bactericidal formulations
US20060263308A1 (en) * 2005-05-17 2006-11-23 Ivonne Brown Method for improving skin radiance and luminosity
US7838045B2 (en) * 2005-08-18 2010-11-23 Ribnicky David M Anti-inflammatory activity of phenethylisothiocyanate (PEITC) and the Barbarea verna seed preparation containing this compound
DE102006035789A1 (de) * 2006-07-28 2008-01-31 Beiersdorf Ag Kosmetische Zubereitung umfassend Folsäure und Parfumbestandteile
KR101234024B1 (ko) * 2006-10-31 2013-02-19 (주)아모레퍼시픽 백매화의 향취를 재현한 향료 조성물
JP5452228B2 (ja) * 2006-10-31 2014-03-26 株式會社アモーレパシフィック 梅の香臭を再現した香料組成物
DE102007026049A1 (de) * 2007-05-31 2008-12-04 Beiersdorf Ag Repellentien gegen Wespen
EP2014273A1 (de) * 2007-06-14 2009-01-14 Symrise GmbH & Co. KG Verwendung von Menthylmethylether und weiterer Ether zum Erzeugen eines Sauberkeits- und/oder Reinlichkeitsgefühls
DE102007038413A1 (de) * 2007-08-09 2009-02-12 Beiersdorf Ag Kosmetische Emulgatorkombination

Also Published As

Publication number Publication date
MX360399B (es) 2018-10-31
CA2713770A1 (en) 2009-08-13
HK1199834A1 (zh) 2015-07-24
EP2257284B1 (en) 2015-03-25
EA020293B1 (ru) 2014-10-30
WO2009099890A2 (en) 2009-08-13
BRPI0907086A2 (pt) 2020-06-16
KR101199672B1 (ko) 2012-11-09
CN101496799A (zh) 2009-08-05
US20190314295A1 (en) 2019-10-17
CA2713770C (en) 2016-09-20
US20100249222A1 (en) 2010-09-30
EA201001195A1 (ru) 2011-04-29
CN103919767B (zh) 2016-03-09
EP2257284A2 (en) 2010-12-08
KR20090084624A (ko) 2009-08-05
CN103919767A (zh) 2014-07-16
ES2540743T3 (es) 2015-07-13
BRPI0907086B1 (pt) 2021-06-22
US20090197939A1 (en) 2009-08-06
CN101496799B (zh) 2014-04-16
US8399521B2 (en) 2013-03-19
WO2009099890A3 (en) 2009-11-05

Similar Documents

Publication Publication Date Title
MX2010008293A (es) Metodos para tratar la piel con ingredientes aromaticos activos en la piel.
NZ701099A (en) Ketol-acid reductoisomerase enzymes and methods of use
MY159971A (en) Multipotent/pluripotent cells and methods
WO2007096601A3 (en) Antimicrobial formulations comprising a quinone and a copper salt
IN2015DN02938A (es)
CL2013000238A1 (es) Uso de inhibores de la succinato deshidrogenasa y/o inhibidores del complejo iii para mejorar la relacion entre microorganismos dañinos y beneficiosos.
PH12014501639A1 (en) Pharmaceutical compositions and methods
CU24048B1 (es) Composiciones para tratar náusea y vómito centralmente mediados
CR11870A (es) Composiciones de perácido y 2-hidroxi ácido orgánico y métodos para tratar productos agrícolas
GB2525835A (en) Composition comprising a diindolymethane and a retinoid to treat a skin condition
BR112012002353A2 (pt) uso de inibidores nkg2d para tratamento de doenças cardiovasculares e metabólicas, tal como diabetes do tipo 2
GB0811955D0 (en) Method
HK1154032A1 (en) A process for the ultrapurification of alginates
BRPI1012715A2 (pt) método para induzir morte celular em células-tronco pluripotentes e células diferenciadas, excluindo miócitos cardíacos.
WO2011129607A8 (en) Method for increasing stem cell activity and stem cells produced thereby
WO2012153336A3 (en) Methods and device for lightening skin complexion
EP2683392A4 (en) CINNAMOMUM BURMANII EXTRACT, EXTRACTION METHOD AND ITS USE AS PROTONAL PUMP DOWNWARD CONTROL, ENZYME HUMAN AND MUCOPROTECTOR
Arrington Telecommuting and job satisfaction: Examining workaholism and work/life balance
UA54289U (ru) Антиоксидантная композиция для обработки яблок перед хранением
Wang Consumer behavior and willingness to pay for orgnaic [ie organic] products
UA55856U (ru) Способ определения биологического эффекта магнитного поля
GB2467284A (en) Sulfatase enzymes
WO2011115447A3 (ko) Ｃ 말단이 절단된 퍼옥시레독신 ⅱ 및 이를 함유한 세포 사멸 예방 및 치료용 조성물
UA33574U (en) Method for plasty of autodermotransplant
UA52992U (ru) Способ оценки токсичности водной среды

Legal Events

Date Code Title Description
FG Grant or registration